Reversair 4 mg OD is an orodispersible tablet containing Montelukast Sodium, a selective leukotriene receptor antagonist manufactured by ACI Limited. It is primarily used for:
Prophylaxis and chronic treatment of asthma
Relief of symptoms of seasonal and perennial allergic rhinitis
Montelukast works by inhibiting the action of leukotrienes, substances in the body that cause inflammation and constriction of airways, thereby reducing asthma symptoms and improving breathing.